IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.791
AS - Asia 13.099
EU - Europa 11.957
SA - Sud America 2.837
AF - Africa 337
Continente sconosciuto - Info sul continente non disponibili 301
OC - Oceania 31
Totale 50.353
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.575
SG - Singapore 4.754
RU - Federazione Russa 3.453
CN - Cina 3.161
IT - Italia 2.845
BR - Brasile 2.218
VN - Vietnam 1.817
GB - Regno Unito 1.767
BD - Bangladesh 956
HK - Hong Kong 924
CA - Canada 846
DE - Germania 846
UA - Ucraina 628
FR - Francia 441
SE - Svezia 436
IN - India 279
FI - Finlandia 273
DK - Danimarca 271
NL - Olanda 228
AR - Argentina 225
MX - Messico 221
IE - Irlanda 190
PL - Polonia 179
IL - Israele 177
TR - Turchia 160
ID - Indonesia 138
EC - Ecuador 127
ES - Italia 114
JP - Giappone 113
PK - Pakistan 111
IQ - Iraq 109
ZA - Sudafrica 107
AT - Austria 72
CO - Colombia 63
MA - Marocco 62
UZ - Uzbekistan 60
VE - Venezuela 59
AE - Emirati Arabi Uniti 43
CL - Cile 42
LT - Lituania 41
PH - Filippine 37
MY - Malesia 36
PY - Paraguay 33
SA - Arabia Saudita 32
KE - Kenya 31
EG - Egitto 28
TN - Tunisia 28
EU - Europa 27
NP - Nepal 27
PE - Perù 25
HN - Honduras 24
UY - Uruguay 23
JM - Giamaica 22
CH - Svizzera 21
RO - Romania 21
CR - Costa Rica 20
BE - Belgio 19
DZ - Algeria 18
AU - Australia 17
JO - Giordania 17
AZ - Azerbaigian 16
TH - Thailandia 15
KR - Corea 14
PT - Portogallo 14
BO - Bolivia 13
KG - Kirghizistan 13
DO - Repubblica Dominicana 12
GR - Grecia 12
NI - Nicaragua 12
PS - Palestinian Territory 12
CZ - Repubblica Ceca 10
GT - Guatemala 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
NZ - Nuova Zelanda 9
PA - Panama 8
TW - Taiwan 8
BG - Bulgaria 7
ET - Etiopia 7
HU - Ungheria 7
KZ - Kazakistan 7
LY - Libia 7
OM - Oman 7
SI - Slovenia 7
AO - Angola 6
BH - Bahrain 6
CI - Costa d'Avorio 6
GE - Georgia 6
IR - Iran 6
MD - Moldavia 6
MG - Madagascar 6
QA - Qatar 6
AL - Albania 5
BB - Barbados 5
CG - Congo 5
GD - Grenada 5
GY - Guiana 5
HR - Croazia 5
MT - Malta 5
NO - Norvegia 5
Totale 49.972
Salva come PNG Salva come JPEG
Città #
Dallas 3.745
Singapore 2.383
Ashburn 1.627
San Jose 1.387
Beijing 1.250
Southend 907
Hong Kong 805
Chandler 734
Los Angeles 656
Moscow 597
Fairfield 585
Council Bluffs 557
Houston 553
Ho Chi Minh City 540
Woodbridge 470
Chicago 449
San Mateo 436
New York 433
Milan 428
Ann Arbor 422
Falls Church 406
Seattle 372
Hanoi 367
Jacksonville 334
Cambridge 333
Wilmington 326
The Dalles 310
Santa Clara 291
Rome 289
Ottawa 257
Buffalo 250
São Paulo 242
Boardman 232
Lauterbourg 224
Hefei 216
Dearborn 214
Dublin 188
Pisa 183
Salt Lake City 180
Portsmouth 170
Stevenage 164
Beauharnois 163
Orem 156
Tel Aviv 154
Warsaw 154
Munich 149
Dong Ket 147
Helsinki 142
London 141
Lawrence 132
Montreal 131
Brooklyn 124
Mexico City 114
Atlanta 102
Denver 102
Tokyo 99
Phoenix 98
Stockholm 92
Frankfurt am Main 90
Poplar 87
Chennai 85
Florence 85
Toronto 85
Tampa 84
Istanbul 77
Amsterdam 75
Johannesburg 73
Da Nang 72
Elk Grove Village 72
Montréal 72
Rio de Janeiro 71
Nuremberg 69
Figino 67
San Diego 65
Haiphong 62
Boston 58
Tashkent 55
Fremont 53
San Francisco 53
Columbus 52
Turin 51
Guayaquil 49
Manchester 49
Naples 48
Ankara 47
Bologna 47
Biên Hòa 45
Mumbai 44
Turku 44
Genoa 43
Brasília 41
Lappeenranta 40
Redwood City 40
Belo Horizonte 39
Miami 38
Paris 37
Quito 37
Washington 37
Dongguan 36
Guangzhou 36
Totale 29.122
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.707
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 628
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 516
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 457
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 402
A simple echocardiographic score to rule out cardiac amyloidosis 394
A simple echocardiographic score to rule out cardiac amyloidosis 371
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 362
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 355
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 349
Central sleep apnea and cardiovascular disease state-of-the-art 346
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 343
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 342
[Central apneas and cardiovascular diseases] 342
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 335
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 335
Prediction of the chemoreflex gain by common clinical variables in heart failure 334
Etiology, clinical presentation, and management of left main coronary artery aneurysms 333
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 333
Treating chemoreflex in heart failure: modulation or demolition? 328
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 323
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 322
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 320
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 320
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 319
Adrenergic activation in heart failure: blockade or rebalance? 316
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 308
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 308
Eligibility for vericiguat in a real‐world, contemporary heart failure population 307
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 306
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 303
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 303
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 299
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 299
Screening the health status of people working in a university 296
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 295
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 293
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 291
How to take arms against central apneas in heart failure 289
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 285
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 284
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 282
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 281
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 278
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 276
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 276
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 270
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 269
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 269
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 268
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 267
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 267
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 267
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 267
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 265
Improved survival in limited scleroderma-related pulmonary artery hypertension 264
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 264
B-type natriuretic peptide secretion following scuba diving 263
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 262
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 262
Valve disease in cardiac amyloidosis: an echocardiographic score 261
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 261
null 258
null 258
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 257
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 257
A Novel Workflow for Electrophysiology Studies in Patients with Brugada Syndrome 254
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 254
null 253
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 251
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 250
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 250
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 249
An atypical case of cardiac amyloidosis. 248
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 247
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 247
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 246
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 246
Renin profiling predicts neurohormonal response to sacubitril/valsartan 244
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 242
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 242
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 241
Role of Imaging in Cardiomyopathies 241
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 241
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing 241
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 240
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 240
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 239
A scoping review of machine learning models to predict risk of falls in elders, without using sensor data 238
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 238
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 237
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 236
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 234
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 233
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 232
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 232
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 231
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 230
Breathless heart: only when the neck is deep in water? 230
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 229
Totale 30.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 245.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 245.611
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.184 0 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.696 65 80 466 207 596 585 1.383 2.351 871 949 1.993 1.150
2025/202626.160 1.363 4.006 2.931 3.638 2.944 1.612 2.391 1.058 1.413 1.557 1.726 1.521
2026/20271.415 760 655 0 0 0 0 0 0 0 0 0 0
Totale 50.353